Zanzalintinib for advanced head and neck cancer
Treatments studied
Part of Cancer clinical trials.
This trial tests a new drug, zanzalintinib, for people with adenoid cystic carcinoma that has come back or spread and can't be treated with local therapy. The drug may help slow or stop the cancer's growth.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You have adenoid cystic carcinoma that has come back or spread and can't be treated with surgery or radiation.
- Your cancer has clearly grown in the last 3 months.
- You have at least one tumor that can be measured on a CT or MRI scan.
- You are able to do your daily activities (performance status 0-1).
- You are willing to have a biopsy of your tumor if needed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new three-drug combination for advanced head and neck cancer that cannot be cured by local treatments. It aims to find the best dose of a targeted therapy called Zanzalintinib when given with two standard immunotherapy and targeted drugs.
This trial tests a new drug called zanzalintinib for people with advanced liver cancer (HCC) that can't be treated with surgery. You may join if your cancer has gotten worse after at least one prior treatment, or you couldn't tolerate that treatment.
This trial tests a new drug called zanzalintinib for people with advanced bladder cancer that has grown after at least one prior treatment. The drug may help shrink tumors or slow their growth.
This study tests a new oral medication called zanzalitinib, which may help slow the growth of advanced prostate cancer that has continued to spread despite hormone therapy and possibly chemotherapy. The goal is to see if the drug is safe and effective for men with this type of cancer.
This trial tests a new drug called zanzalintinib for people with advanced or metastatic bone sarcomas that have not responded to standard treatments. It aims to see if the drug can help shrink or slow the growth of these tumors.
This trial tests a drug called zanzalintinib for people with advanced thyroid cancer that has spread nearby. The goal is to see if taking this pill before surgery can shrink the tumor and make it easier to remove.
Hear when a new Adenoid Cystic Carcinoma of the Salivary Gland trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.